Sign inJoin waitlistJoin the waitlist

Daniel Coyne

Director, Medical Multispecialty Outpatient Group, CAM · Washington University/B-JH/SLCH Consortium

Credentials: · · · ·

History

Chromalloy American Kidney Center · Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present

Nephrology
Washington University/B-JH/SLCH Consortium
1986–1988
Internal Medicine
1983–1986
Case Western Reserve University School of Medicine
1979–1983

Research

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
New England Journal of Medicine · 2004 · 819 citations
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
The Lancet · 2010 · 546 citations
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States
The American Journal of Medicine · 2003 · 365 citations

Stuart Sprague
9 papers
Rajiv Agarwal
7 papers
Steven Cheng
7 papers
SF
Steven Fishbane
7 papers
Aubrey Morrison
6 papers
DW
David Warnock
6 papers
BM
Beckie Michael
5 papers
Kamyar Kalantar-Zadeh
5 papers
Samuel Dagogo-Jack
5 papers
Daniel Batlle
4 papers
DB
Daniel Brennan
4 papers
JD
James Delmez
4 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $35.7K · Washington University
2005–2006

Clinical trials

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
Principal investigator · Completed · Phase 4
Washington University School of Medicine
2009–2013
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2006–2007